Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

EHRs enhance quality of patient care in community-based settings

A new study by Weill Cornell Medical College researchers, published in the Journal of General Internal Medicine, provides compelling evidence that electronic health records (EHRs) enhance the quality of patient care in a community-based setting with multiple payers, which is representative of how medicine is generally practiced across the United States.

10 Oct 2012

Chronic kidney disease changes the composition of intestinal bacterial microbes

Chronic kidney disease changes the composition of intestinal bacterial microbes that normally play a crucial role in staving off disease-causing pathogens and maintaining micronutrient balance, according to UC Irvine researchers.

10 Oct 2012

People with lower socioeconomic status remain at higher risk of dying from colon cancer

Despite medical advances in colon cancer screening and treatment, people with a lower socioeconomic status remain at a higher risk of dying from colon cancer. A new study in The Milbank Quarterly finds that states and communities that focus on increasing the adoption of innovative health care practices along with providing greater access to public health information can reduce these deaths.

6 Oct 2012

Researchers determine function of new IKKα enzyme variant in colorectal cancer

Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions of colorectal cancer.

5 Oct 2012

Diclofenac increases risk for anastomotic leakage after colorectal surgery

The use of cyclo-oxygenase-2 nonsteroidal anti-inflammatory drugs increases the risk for anastomotic leakage after colorectal surgery, research shows.

4 Oct 2012

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

XBiotech, a privately held biotechnology company, announced today that the company has been granted Fast Track designation for its anti-cachexia drug Xilonix.

4 Oct 2012

New colonoscopy surveillance guidelines from U.S. Multisociety Task Force

Patients at average risk of colorectal cancer who have a clean colonoscopy do not need to repeat the test for 10 years. This and many other practical recommendations for cancer prevention were issued in "Guidelines for Colonoscopy Surveillance After Screening and Polypectomy," a consensus update issued by the U.S. Multisociety Task Force on Colorectal Cancer.

3 Oct 2012

New insights on global fight to prevent cancers

New insights on the global fight to prevent cancers were presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The studies highlight the challenges of overcoming misunderstandings about how important lifestyle factors are in reducing cancer risk.

1 Oct 2012

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Exelixis, Inc. today reported preliminary data from an ongoing phase 1 dose escalation study of cabozantinib in Japan.

1 Oct 2012

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).

1 Oct 2012

Research roundup: Saving money with hospital observation units, total knee replacement rates skyrocketing, Medicare patients and antibiotic overuse

The authors write: Using observation units in hospitals to provide care to certain patients can be more efficient than admitting them to the hospital and can result in shorter lengths-of-stay and lower costs. However, such units are present in only about one-third of US hospitals.

29 Sep 2012

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).

28 Sep 2012

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.

27 Sep 2012

EPO grants patent to Rexahn’s new isoquinolinamine compounds for cancer

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 2099765 to Rexahn, entitled "5, 6, or 7-Substituted-3-arylisoquinolinamine derivatives as antitumor agents."

27 Sep 2012

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

Uncovering colon cancer's genetic roots is the focus of a new $13 million, four-year, National Cancer Institute-funded project at Fred Hutchinson Cancer Research Center. Ulrike (Riki) Peters, Ph.D., M.P.H., a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort. She and her colleagues will use next-generation sequencing, a technique that captures entire genome sequences, to identify genetic links to colorectal cancer.

27 Sep 2012

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

PsiOxus Therapeutics, Ltd. has treated the first patient in its phase I/II clinical trial of ColoAd1for the treatment of metastatic solid tumours.

26 Sep 2012

UAB urges women to get tested for key measures throughout their lives

Heart disease, cancer and stroke are the leading causes of death in women of all ages in the United States, according to the Centers for Disease Control and Prevention. To get ahead of these chronic health issues and possibly prevent them from worsening, experts at the University of Alabama at Birmingham urge women to get tested for key measures throughout their lives.

21 Sep 2012

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

On Aug. 8, Massachusetts' third health care cost control bill became law. It "sets annual state spending targets, encourages the formation of accountable care organizations, and establishes an independent commission to oversee health care system performance."

21 Sep 2012

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. In addition, the incidence and mortality rates of colorectal cancer are on the rise. Recently, metabolic genes have received increasing and specific attention due to their potential role in carcinogenesis.

20 Sep 2012

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.

18 Sep 2012

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

EHRs enhance quality of patient care in community-based settings

Chronic kidney disease changes the composition of intestinal bacterial microbes

People with lower socioeconomic status remain at higher risk of dying from colon cancer

Researchers determine function of new IKKα enzyme variant in colorectal cancer

Diclofenac increases risk for anastomotic leakage after colorectal surgery

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

New colonoscopy surveillance guidelines from U.S. Multisociety Task Force

New insights on global fight to prevent cancers

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Research roundup: Saving money with hospital observation units, total knee replacement rates skyrocketing, Medicare patients and antibiotic overuse

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

EPO grants patent to Rexahn’s new isoquinolinamine compounds for cancer

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

PsiOxus initiates ColoAd1 phase I/II trial in metastatic solid tumours

UAB urges women to get tested for key measures throughout their lives

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in